INSM Antibodies

Santa Cruz Biotechnology provides a broad selection of INSM Antibodies for investigating insulinoma-associated protein 1 (INSM1) in research applications. Monoclonal INSM Antibodies are validated for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). INSM1 functions as a transcription factor with essential roles in neuroendocrine differentiation and appears predominantly in neuroendocrine tumors. Understanding INSM1 regulation provides critical insights into neuroendocrine cell development and function, establishing INSM1 as a key marker for tumor research and diagnosis. INSM1 research advances knowledge in tumor biology while identifying potential therapeutic approaches. Investigating INSM1 expression patterns helps reveal mechanisms underlying neuroendocrine tumor development and progression. Detailed characterization of INSM1 activity contributes to understanding cellular signaling networks in both normal and disease states. Research utilizing INSM1 monoclonal antibodies from Santa Cruz Biotechnology continues to advance scientific understanding of neuroendocrine development and disease mechanisms.